COVID‐19 outcomes of patients with gynaecologic cancer in New York City
Women receiving standard treatment in New York City for ovarian, uterine, and cervical cancers are…
Browsing: ovarian cancer
Widening cancer gene testing is cost effective and could prevent millions of cancer cases
Screening entire populations for breast and ovarian cancer gene mutations could prevent millions more breast…
Researchers identify immune effects of drug in aggressive ovarian cancer
A drug known as SP-2577 could help enable the body’s own immune system to attack…
Breakthrough with cancer vaccine
Scientists are ready to trial a new cancer vaccine in humans following the successful outcome…
New test paves the way for tailored treatment of deadliest form of ovarian cancer
A new tool will help researchers and clinicians to classify ovarian cancer patients’ tumours into…
New Approach to Ovarian Cancer Treatment
Overall survival from ovarian cancer has not improved for several decades. Now, a Peter Mac-led…
Study confirms important clues to fight ovarian cancer
The rogue cellular engine that drives a majority of ovarian cancers remains frustratingly difficult to…
Personalised ovarian cancer risk prediction reduces worries
Offering personalised ovarian cancer risk prediction to women shows that 98 per cent of participants…
Funding to boost research into new therapy combinations for ovarian cancer
Peter Mac researchers have been awarded a four year grant from the Federal Government’s Medical…
ASCO 2020: Maintenance therapy With PARP inhibitor olaparib extends survival by over 1 year in patients with relapsed ovarian cancer and BRCA mutation
Maintenance therapy with olaparib extended overall survival by nearly 13 months (12.9) compared with placebo…